Oregon's Senate Committee just approved a significant amendment to drug transparency legislation that will hold manufacturers accountable for patient assistance programs starting in 2028!
Click to read more!
#OR #PatientAssistancePrograms #PharmaceuticalCosts #HealthcareTransparency